Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)

Hong Kong · Delayed Price · Currency is HKD

7.10

-0.01 (-0.14%)

At close: Apr 17, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Pharmaceuticals	1.31B	1.37B	1.29B	1.13B	1.31B
Pharmaceuticals Growth	-4.59%	6.35%	14.40%	-13.91%	-
Total	1.31B	1.37B	1.29B	1.13B	1.31B
Total Growth	-4.59%	6.35%	14.40%	-13.91%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Mainland China	1.26B	1.32B	1.25B	1.07B	1.17B
Mainland China Growth	-4.18%	5.65%	16.01%	-8.29%	-
Other Countries/Regions	45.47M	53.30M	41.91M	51.80M	136.57M
Other Countries/Regions Growth	-14.69%	27.18%	-19.09%	-62.07%	-
Total	1.31B	1.37B	1.29B	1.13B	1.31B
Total Growth	-4.59%	6.35%	14.40%	-13.91%	-

Source: S&P Global Market Intelligence.